help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Endocrinology, doi:10.1210/en.2005-0038
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
146/6/2834    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bresson, D.
Right arrow Articles by Peraldi-Roux, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bresson, D.
Right arrow Articles by Peraldi-Roux, S.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Substance via MeSH
*Genetics Home Reference
Endocrinology Vol. 146, No. 6 2834-2844
Copyright © 2005 by The Endocrine Society

New Insights into the Conformational Dominant Epitopes on Thyroid Peroxidase Recognized by Human Autoantibodies

Damien Bresson, Sandra A. Rebuffat, Brigitte Nguyen, J. Paul Banga, Andrzej Gardas and Sylvie Peraldi-Roux

Centre National de la Recherche Scientifique Unité Mixte de Recherche 5160 (D.B., S.A.R., B.N., S.P.-R.), Centre de Pharmacologie et Biotechnologie pour la Santé, Faculté de Pharmacie, BP 14491, 34093 Montpellier Cedex 5, France; Medical Centre of Postgraduate Education (A.G.), 01-813 Warsaw, Poland; and Division of Medicine (J.P.B.), Guy’s, King’s, and St. Thomas’ School of Medicine, King’s College London, London, United Kingdom SE1 9RT

Address all correspondence and requests for reprints to: Dr. Sylvie Péraldi-Roux, Centre National de la Recherche Scientifique UMR 5160, Centre de Pharmacologie et Biotechnologie pour la Santé, 15 avenue Charles Flahault, BP 14491, 34093 Montpellier, Cedex 5, France. E-mail: sylvie.roux{at}ibph.pharma.univ-montp1.fr.

Human anti-thyroperoxidase (TPO) autoantibodies (aAbs) are a major hallmark of autoimmune thyroid diseases. Their epitopes are discontinuous and mainly restricted to an immunodominant region (IDR) consisting of two overlapping regions (IDR/A and B). To shed light on the relationship between these regions, we first performed competitive studies using all available reference anti-TPO antibodies. Interestingly, we showed that human IDR/A- and B-specific anti-TPO aAbs recognized essentially the same regions on the TPO molecule. However, our data also indicated that IDR/A-specific human aAbs strongly recognized the region containing residues 599–617, whereas the IDR/B-specific aAbs bind to several regions as well as region 599–617. Next, we scanned this key region to identify the residues involved in the immunodominant autoepitope. Using peptide spot technology together with competitive ELISA experiments, we demonstrated that residues 604ETP-DL609 play a major role in the anti-peptide P14 epitope and that IDR/A-specific human anti-TPO aAbs, either expressed as recombinant Fab or obtained from Graves’ disease patients, specifically recognize the sequences 597FCGLPRLE604 and 611TAIASRSV618. All together our data emphasize that both the IDRs involve the same surface area on human TPO, but the differential usage of one or the other regions leads to different inhibition patterns in competitive experiments. In conclusion, our data help to resolve the long-sought issue on the molecular immunology of the two IDRs on TPO and provide new clues to design efficient peptides that may be part of a combinatorial treatment aiming at delaying development of autoimmune thyroiditis when used prophylactically.




This article has been cited by other articles:


Home page
EndocrinologyHome page
M. Dubska, J. P. Banga, D. Plochocka, G. Hoser, E. H. Kemp, B. J. Sutton, A. Gardas, and M. Gora
Structural Insights into Autoreactive Determinants in Thyroid Peroxidase Composed of Discontinuous and Multiple Key Contact Amino Acid Residues Contributing to Epitopes Recognized by Patients' Autoantibodies
Endocrinology, December 1, 2006; 147(12): 5995 - 6003.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
S. A. Rebuffat, D. Bresson, B. Nguyen, and S. Peraldi-Roux
The key residues in the immunodominant region 353-363 of human thyroid peroxidase were identified
Int. Immunol., July 1, 2006; 18(7): 1091 - 1099.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
H. P. Ng and A. W. C. Kung
Induction of Autoimmune Thyroiditis and Hypothyroidism by Immunization of Immunoactive T Cell Epitope of Thyroid Peroxidase
Endocrinology, June 1, 2006; 147(6): 3085 - 3092.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2005 by The Endocrine Society